FDA Import Refusal 1FX-1726778-2/10002/1I — CKD BIO CORPORATION
The FDA refused shipment 1FX-1726778-2/10002/1I from CKD BIO CORPORATION (South Korea) on Sep 18, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charge: 75 This firm has 4 other import refusals on record.
Refusal details
- Date
- Sep 18, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 58PDY05 ONABOTULINUMTOXINA
- Charges
- 75